This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/ontology/domain/vavai/cep/typPojektu/
n19http://linked.opendata.cz/ontology/domain/vavai/cep/zivotniCyklusProjektu/
n7http://linked.opendata.cz/ontology/domain/vavai/cep/druhSouteze/
n22http://linked.opendata.cz/ontology/domain/vavai/cep/hodnoceniProjektu/
dctermshttp://purl.org/dc/terms/
n2http://linked.opendata.cz/resource/domain/vavai/projekt/
n21http://linked.opendata.cz/resource/domain/vavai/cep/prideleniPodpory/
n10http://linked.opendata.cz/resource/domain/vavai/subjekt/
n20http://linked.opendata.cz/ontology/domain/vavai/cep/kategorie/
n8http://linked.opendata.cz/ontology/domain/vavai/
n18http://linked.opendata.cz/ontology/domain/vavai/cep/duvernostUdaju/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n9http://linked.opendata.cz/ontology/domain/vavai/cep/obor/
n6http://linked.opendata.cz/ontology/domain/vavai/cep/fazeProjektu/
n4http://linked.opendata.cz/ontology/domain/vavai/cep/statusZobrazovaneFaze/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/domain/vavai/projekt/7E09019/
n3http://linked.opendata.cz/ontology/domain/vavai/cep/
n15http://linked.opendata.cz/resource/domain/vavai/cep/vyzva/
n17http://reference.data.gov.uk/id/gregorian-year/
n13http://linked.opendata.cz/resource/domain/vavai/aktivita/

Statements

Subject Item
n2:7E09019
rdf:type
n8:Projekt
rdfs:seeAlso
http://www.isvav.cz/projectDetail.do?rowId=7E09019
dcterms:description
In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collection, handling, stabilisation and storage of biosamples which limits the reproducibility of subsequent diagnoses, and (b) its scale is restrained to the cellular level. To address this first point, this IP, SPIDIA, built of clinicians, academics, tool and assay developers, aims at developing quality guidelines for molecular in vitro diagnostics and to standardise the pre-analytical workflow in related procedures. Regarding the second point, SPIDIA aims at developing modern pre-analytical tools for diagnostics improving the stabilisation, handling and study of free biomolecules within blood, plasma, serum, tissues and tumours. Recent discoveries have revealed that RNA, DNA or proteins, released from pathological sites, like tumour cells or Alzheimer’s disease (AD) brain lesions, into the blood or as a secondary blood based response to the disease can serve In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collection, handling, stabilisation and storage of biosamples which limits the reproducibility of subsequent diagnoses, and (b) its scale is restrained to the cellular level. To address this first point, this IP, SPIDIA, built of clinicians, academics, tool and assay developers, aims at developing quality guidelines for molecular in vitro diagnostics and to standardise the pre-analytical workflow in related procedures. Regarding the second point, SPIDIA aims at developing modern pre-analytical tools for diagnostics improving the stabilisation, handling and study of free biomolecules within blood, plasma, serum, tissues and tumours. Recent discoveries have revealed that RNA, DNA or proteins, released from pathological sites, like tumour cells or Alzheimer’s disease (AD) brain lesions, into the blood or as a secondary blood based response to the disease can serve
dcterms:title
Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics
skos:notation
7E09019
n3:aktivita
n13:7E
n3:celkovaStatniPodpora
n12:celkovaStatniPodpora
n3:celkoveNaklady
n12:celkoveNaklady
n3:datumDodatniDoRIV
2013-06-28+02:00
n3:druhSouteze
n7:RP
n3:duvernostUdaju
n18:S
n3:fazeProjektu
n6:92901795
n3:hlavniObor
n9:FP
n3:hodnoceniProjektu
n22:U
n3:kategorie
n20:ZV
n3:klicovaSlova
Standards; pre-analytical phase; in vitro diagnostics; molecular diagnostics; diagnostic tools; biomarkers; biomedical research; blood sample; tumour sample; tissue sample; quality assurance; sample collection; sample handling; sample stabilisation
n3:partnetrHlavni
n10:ico%3A86652036
n3:pocetKoordinujicichPrijemcu
0
n3:pocetPrijemcu
1
n3:pocetSpoluPrijemcu
0
n3:pocetVysledkuRIV
0
n3:pocetZverejnenychVysledkuVRIV
0
n3:posledniUvolneniVMinulemRoce
2012-03-19+01:00
n3:prideleniPodpory
n21:1086%2F2011-321
n3:sberDatUcastniciPoslednihoRoku
n17:2012
n3:sberDatUdajeProjZameru
n17:2013
n3:statusZobrazovaneFaze
n4:DUU
n3:typPojektu
n11:P
n3:ukonceniReseni
2012-09-30+02:00
n3:vedlejsiObor
n9:EB
n3:zahajeniReseni
2009-10-01+02:00
n3:zhodnoceni+vysledku+projektu+dodavatelem
Hodnocení výsledků řešení ministerstvo neprovádí, neboť podmínkou podpory je, že uchazeč byl vybrán mezinárodním poskytovatelem v souladu s pravidly příslušného programu. Projekt je hodnocen až po jeho schválení mezinárodním poskytovatelem. Following the condition that the candidate of financial contribution was evaluated and afterwards selected by international provider in accordance with the rules of the program the Ministry of Education, Youth ans Sports does not realize the evaluation of project results. The project is evaluated only after its approval by an international provider.
n3:zivotniCyklusProjektu
n19:ZBBKU
n3:vyzva
n15:FP7-Health-2009-two-stage
n3:klicoveSlovo
biomedical research biomarkers molecular diagnostics sample collection diagnostic tools in vitro diagnostics Standards sample handling tumour sample pre-analytical phase quality assurance tissue sample blood sample